| Product Code: ETC13371208 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 0.48 Billion |
| Forecast Size (2032) | USD 0.76 Billion |
| CAGR | 5.30% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Phase II |
| Fastest Growing Segment | Phase I |
| Leading Companies | Covance, Charles River Laboratories, Zoetis, Elanco, and Intervet |

The Global Veterinary Clinical Trials Market was estimated at USD 0.48 Billion in 2025 and is projected to reach USD 0.76 Billion by 2032, growing at a CAGR of 5.30% from 2026 to 2032.
The Global Veterinary Clinical Trials Market is positioned for notable transformations as demand for advanced veterinary therapies escalates. Particularly, the surge in companion animal clinical trials reflects growing investments in research and development, aimed at tackling emerging health challenges faced by pets. These trends underline the market's essential role in fostering innovation in veterinary medicine.
Current dynamics highlight a shift toward more personalized and precision veterinary medicines, greatly influenced by the increasing prevalence of chronic diseases among animals. This transformation is further bolstered by collaborations between pharmaceutical companies and academia, encouraging a more robust clinical trials framework that meets the specific needs of animal healthcare.
This graph illustrates the annual growth rates of the Global Veterinary Clinical Trials Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 5.8 | Investment in veterinary clinical trials is strengthening foundational market structures and capabilities. |
| 2023 | 9.01 | Veterinary clinics are adapting their supply chains to improve trial efficiency and outcomes. |
| 2024 | 7.67 | Expanding clinical trial pipelines within veterinary medicine enhances competitive positioning among providers. |
| 2025 | 4.75 | Veterinary practices increasingly prioritize sustainability to meet trial-related environmental standards. |
| 2026 | 9.4 | Regulatory changes by the FDA facilitate faster approvals for veterinary clinical trial drugs. |
| 2027 | 4.71 | Increased accessibility to veterinary care in rural areas boosts clinical trial participant enrollment. |
| 2028 | 5.39 | Diagnostic imaging advancements are enhancing the effectiveness of veterinary clinical trial methodologies. |
| 2029 | 10.66 | In North America, pet owners are becoming more engaged in veterinary clinical trials for new therapies. |
| 2030 | 2.19 | A shift toward rising raw material costs influences veterinary clinical trial expenses and funding. |
| 2031 | 7.9 | While pet owners demand more advanced treatment options, trials must adapt to their preferences. |
| 2032 | 7.49 | Wearable monitoring devices are becoming essential for collecting real-time data in clinical trials. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
Several restraints impact the Global Veterinary Clinical Trials Market, particularly high costs associated with study execution, which can reach upwards of $350,000 for comprehensive trials. Regulatory hurdles across jurisdictions also pose challenges, limiting the speed and efficiency of conducting clinical trials. For example, FDA regulations often require extensive documentation and review, which can prolong the trial process. Additionally, recruiting animals for participation can be a complex endeavor, especially when pet owners are hesitant to allow their animals to be involved in trials due to ethical concerns.
One trend reshaping the landscape is the shift towards personalized medicine in veterinary care. Companies like Zoetis are exploring targeted therapies that are tailored to the specific needs of animals, focusing on conditions like cancer and chronic diseases, which demand more refined treatment approaches. Furthermore, the integration of telehealth services within veterinary practices is becoming increasingly prevalent, enabling remote monitoring of animal health, thus allowing for more agile clinical trial methodologies. For example, a study reported in 2023 showed that telemedicine led to a 30% improvement in trial enrollees' engagement, enhancing the overall data quality.
Emerging revenue opportunities within the market include the rise of regenerative medicine applications, driven by entities like VetStem, which focuses on stem cell therapies for treatment of various animal ailments. The anticipated growth in the prevalence of infectious diseases also paves the way for innovative clinical trials aimed at combating such threats. Additionally, partnerships with research institutions could drive more focused veterinarian studies and yield better therapeutic results. One notable collaboration, set to commence in late 2025, aims to invest over $5 million in understanding feline diseases, reflecting both financial commitment and market urgency.
The leading segment in trial phases for the Global Veterinary Clinical Trials Market is Phase II, commanding a share of approximately ~45% in 2025. Phase I, while currently smaller, is expected to see accelerated growth, with a projected CAGR of 6.5% from 2026 to 2032. This growth is attributed to increased interest in early-stage assessments that facilitate understanding of the safety and efficacy of new treatments, crucial for gaining quicker regulatory approvals and advancing product development.
In terms of study types, Interventional trials currently hold the largest market share of approximately ~60% in 2025. Observational trials are poised to grow rapidly, with a CAGR of 7.0% from 2026 to 2032. This growth is primarily driven by a growing emphasis on real-world evidence and the need for data that better reflects animal health outcomes in everyday settings, catering to both researchers and regulatory bodies focused on improving veterinary medications.
Oncology leads the therapeutic areas, capturing about ~50% of the market share in 2025. Infectious Diseases is anticipated to experience a robust CAGR of 8.2% from 2026 to 2032, fueled by increasing concerns over zoonotic diseases and a rising global focus on animal welfare. This shift in veterinary medicine towards preventive care and effective treatment protocols is expected to create a compelling need for targeted trials aimed at curbing the impact of infectious pathogens.
Dogs dominate the Global Veterinary Clinical Trials Market, representing approximately ~52% of the share in 2025. Horses are noted for a significant growth trajectory, projected to experience a CAGR of 7.0% from 2026 to 2032. This can be attributed to the niche applications of advanced veterinary care in equine athletes, where the demand for clinical trials assessing performance-related health issues is escalating rapidly within competitive sporting environments.
Research Institutes account for the largest share of the Global Veterinary Clinical Trials Market, with approximately ~55% in 2025. Conversely, Pharmaceutical Companies are superseding growth expectations, enjoying a CAGR of 6.8% from 2026 to 2032. This trend is largely due to their increasing investments in developing novel treatments and therapeutics, compounded by a drive toward optimizing clinical trial efficiencies and accelerating time to market for new veterinary products.
North America leads the Global Veterinary Clinical Trials Market, holding a significant share of ~48% in 2025. However, Asia is projected to experience the fastest growth with a CAGR of 7.6% from 2026 to 2032. This increase is driven by a burgeoning pet population and growing investment in veterinary healthcare infrastructure, complemented by supportive government initiatives encouraging animal health research and product development.
The regulatory environment governing the Global Veterinary Clinical Trials Market is evolving, with numerous initiatives aimed at enhancing animal health research and development. These initiatives are geared towards streamlining the approval processes, encouraging innovation, and ensuring the welfare of animal participants in clinical trials.
The Global Veterinary Clinical Trials Market is expected to experience structural shifts driven by advancements in data analytics and artificial intelligence. Companies like Charles River Laboratories are increasingly leveraging these technologies to enhance trial efficiencies and reduce costs, which will likely encourage a broader array of clinical studies for various animal breeds. As regulatory bodies adapt to these methodologies, the integration of real-time data collection will streamline the approval processes and pave the way for innovative therapeutic strategies by 2032.
Recent strategic initiatives from leading companies underscore the evolving dynamics within the Global Veterinary Clinical Trials Market. These developments are not just enhancements of capabilities, but they are reshaping the competitive landscape significantly.
The Global Veterinary Clinical Trials Market is characterized by a competitive structure that is slightly fragmented. While a few major players dominate, numerous regional firms are capitalizing on niche opportunities and specialized services, particularly in therapeutic areas like oncology and infectious diseases.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Covance | Extensive network of preclinical and clinical development services | Enhancing trial capacities and leveraging data analytics |
| Charles River Laboratories | Innovative preclinical models and services | Adopting AI for trial efficiencies and safety assessments |
| Zoetis | Strong focus on animal health pharmaceuticals | Developing targeted therapies for chronic diseases |
| Elanco | Robust portfolio in companion animal health | Oncology-focused clinical trial initiatives |
| Intervet | Expertise in vaccine development and infectious diseases | Advancing preventive care strategies for animals |
These companies are strategically enhancing their positions, establishing partnerships, and focusing on innovation to adapt to the fast-evolving needs within veterinary clinical trials, ensuring a competitive edge in the market.
Global Veterinary Clinical Trials Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Veterinary Clinical Trials Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Veterinary Clinical Trials Market Revenues & Volume, 2022 & 2032F |
3.3 Global Veterinary Clinical Trials Market - Industry Life Cycle |
3.4 Global Veterinary Clinical Trials Market - Porter's Five Forces |
3.5 Global Veterinary Clinical Trials Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Veterinary Clinical Trials Market Revenues & Volume Share, By Trial Phase, 2022 & 2032F |
3.7 Global Veterinary Clinical Trials Market Revenues & Volume Share, By Study Type, 2022 & 2032F |
3.8 Global Veterinary Clinical Trials Market Revenues & Volume Share, By Therapeutic Area, 2022 & 2032F |
3.9 Global Veterinary Clinical Trials Market Revenues & Volume Share, By Animal Type, 2022 & 2032F |
3.10 Global Veterinary Clinical Trials Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Global Veterinary Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Veterinary Clinical Trials Market Trends |
6 Global Veterinary Clinical Trials Market, 2022-2032 |
6.1 Global Veterinary Clinical Trials Market, Revenues & Volume, By Trial Phase, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Veterinary Clinical Trials Market, Revenues & Volume, By Phase I, 2022-2032 |
6.1.3 Global Veterinary Clinical Trials Market, Revenues & Volume, By Phase II, 2022-2032 |
6.2 Global Veterinary Clinical Trials Market, Revenues & Volume, By Study Type, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Veterinary Clinical Trials Market, Revenues & Volume, By Observational, 2022-2032 |
6.2.3 Global Veterinary Clinical Trials Market, Revenues & Volume, By Interventional, 2022-2032 |
6.3 Global Veterinary Clinical Trials Market, Revenues & Volume, By Therapeutic Area, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Veterinary Clinical Trials Market, Revenues & Volume, By Oncology, 2022-2032 |
6.3.3 Global Veterinary Clinical Trials Market, Revenues & Volume, By Infectious Diseases, 2022-2032 |
6.4 Global Veterinary Clinical Trials Market, Revenues & Volume, By Animal Type, 2022-2032 |
6.4.1 Overview & Analysis |
6.4.2 Global Veterinary Clinical Trials Market, Revenues & Volume, By Dogs, 2022-2032 |
6.4.3 Global Veterinary Clinical Trials Market, Revenues & Volume, By Horses, 2022-2032 |
6.5 Global Veterinary Clinical Trials Market, Revenues & Volume, By End User, 2022-2032 |
6.5.1 Overview & Analysis |
6.5.2 Global Veterinary Clinical Trials Market, Revenues & Volume, By Research Institutes, 2022-2032 |
6.5.3 Global Veterinary Clinical Trials Market, Revenues & Volume, By Pharmaceutical Companies, 2022-2032 |
7 North America Veterinary Clinical Trials Market, Overview & Analysis |
7.1 North America Veterinary Clinical Trials Market Revenues & Volume, 2022-2032 |
7.2 North America Veterinary Clinical Trials Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
7.3 North America Veterinary Clinical Trials Market, Revenues & Volume, By Trial Phase, 2022-2032 |
7.4 North America Veterinary Clinical Trials Market, Revenues & Volume, By Study Type, 2022-2032 |
7.5 North America Veterinary Clinical Trials Market, Revenues & Volume, By Therapeutic Area, 2022-2032 |
7.6 North America Veterinary Clinical Trials Market, Revenues & Volume, By Animal Type, 2022-2032 |
7.7 North America Veterinary Clinical Trials Market, Revenues & Volume, By End User, 2022-2032 |
8 Latin America (LATAM) Veterinary Clinical Trials Market, Overview & Analysis |
8.1 Latin America (LATAM) Veterinary Clinical Trials Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Veterinary Clinical Trials Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Veterinary Clinical Trials Market, Revenues & Volume, By Trial Phase, 2022-2032 |
8.4 Latin America (LATAM) Veterinary Clinical Trials Market, Revenues & Volume, By Study Type, 2022-2032 |
8.5 Latin America (LATAM) Veterinary Clinical Trials Market, Revenues & Volume, By Therapeutic Area, 2022-2032 |
8.6 Latin America (LATAM) Veterinary Clinical Trials Market, Revenues & Volume, By Animal Type, 2022-2032 |
8.7 Latin America (LATAM) Veterinary Clinical Trials Market, Revenues & Volume, By End User, 2022-2032 |
9 Asia Veterinary Clinical Trials Market, Overview & Analysis |
9.1 Asia Veterinary Clinical Trials Market Revenues & Volume, 2022-2032 |
9.2 Asia Veterinary Clinical Trials Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
9.2.2 China Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
9.3 Asia Veterinary Clinical Trials Market, Revenues & Volume, By Trial Phase, 2022-2032 |
9.4 Asia Veterinary Clinical Trials Market, Revenues & Volume, By Study Type, 2022-2032 |
9.5 Asia Veterinary Clinical Trials Market, Revenues & Volume, By Therapeutic Area, 2022-2032 |
9.6 Asia Veterinary Clinical Trials Market, Revenues & Volume, By Animal Type, 2022-2032 |
9.7 Asia Veterinary Clinical Trials Market, Revenues & Volume, By End User, 2022-2032 |
10 Africa Veterinary Clinical Trials Market, Overview & Analysis |
10.1 Africa Veterinary Clinical Trials Market Revenues & Volume, 2022-2032 |
10.2 Africa Veterinary Clinical Trials Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
10.3 Africa Veterinary Clinical Trials Market, Revenues & Volume, By Trial Phase, 2022-2032 |
10.4 Africa Veterinary Clinical Trials Market, Revenues & Volume, By Study Type, 2022-2032 |
10.5 Africa Veterinary Clinical Trials Market, Revenues & Volume, By Therapeutic Area, 2022-2032 |
10.6 Africa Veterinary Clinical Trials Market, Revenues & Volume, By Animal Type, 2022-2032 |
10.7 Africa Veterinary Clinical Trials Market, Revenues & Volume, By End User, 2022-2032 |
11 Europe Veterinary Clinical Trials Market, Overview & Analysis |
11.1 Europe Veterinary Clinical Trials Market Revenues & Volume, 2022-2032 |
11.2 Europe Veterinary Clinical Trials Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
11.2.3 France Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
11.3 Europe Veterinary Clinical Trials Market, Revenues & Volume, By Trial Phase, 2022-2032 |
11.4 Europe Veterinary Clinical Trials Market, Revenues & Volume, By Study Type, 2022-2032 |
11.5 Europe Veterinary Clinical Trials Market, Revenues & Volume, By Therapeutic Area, 2022-2032 |
11.6 Europe Veterinary Clinical Trials Market, Revenues & Volume, By Animal Type, 2022-2032 |
11.7 Europe Veterinary Clinical Trials Market, Revenues & Volume, By End User, 2022-2032 |
12 Middle East Veterinary Clinical Trials Market, Overview & Analysis |
12.1 Middle East Veterinary Clinical Trials Market Revenues & Volume, 2022-2032 |
12.2 Middle East Veterinary Clinical Trials Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Veterinary Clinical Trials Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Veterinary Clinical Trials Market, Revenues & Volume, By Trial Phase, 2022-2032 |
12.4 Middle East Veterinary Clinical Trials Market, Revenues & Volume, By Study Type, 2022-2032 |
12.5 Middle East Veterinary Clinical Trials Market, Revenues & Volume, By Therapeutic Area, 2022-2032 |
12.6 Middle East Veterinary Clinical Trials Market, Revenues & Volume, By Animal Type, 2022-2032 |
12.7 Middle East Veterinary Clinical Trials Market, Revenues & Volume, By End User, 2022-2032 |
13 Global Veterinary Clinical Trials Market Key Performance Indicators |
14 Global Veterinary Clinical Trials Market - Export/Import By Countries Assessment |
15 Global Veterinary Clinical Trials Market - Opportunity Assessment |
15.1 Global Veterinary Clinical Trials Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Veterinary Clinical Trials Market Opportunity Assessment, By Trial Phase, 2022 & 2032F |
15.3 Global Veterinary Clinical Trials Market Opportunity Assessment, By Study Type, 2022 & 2032F |
15.4 Global Veterinary Clinical Trials Market Opportunity Assessment, By Therapeutic Area, 2022 & 2032F |
15.5 Global Veterinary Clinical Trials Market Opportunity Assessment, By Animal Type, 2022 & 2032F |
15.6 Global Veterinary Clinical Trials Market Opportunity Assessment, By End User, 2022 & 2032F |
16 Global Veterinary Clinical Trials Market - Competitive Landscape |
16.1 Global Veterinary Clinical Trials Market Revenue Share, By Companies, 2025 |
16.2 Global Veterinary Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here